Advertisement Invitrogen and Active Motif join hands in gene analysis - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Invitrogen and Active Motif join hands in gene analysis

Invitrogen and Active Motif have announced a joint project to explore the use of field programmable gate array technology for the analysis of next-generation sequencing data.

Active Motif’s TimeLogic search appliances couple a field programmable gate array technology (FPGA) accelerator with optimized genomics algorithms to rapidly compare novel sequences to databases of well-characterized genes, helping scientists reveal the purpose and value of their sequence data.

The TimeLogic solutions can deliver the performance of thousands of central processing units, yet are extremely power-efficient, require minimal maintenance, and can be ‘rewired’ with software updates to ensure a long product lifespan.

Joe Fernandez, CEO of Active Motif, said: “We look forward to working with Invitrogen to explore ways in which our technology can speed the processing of data directly from next-generation sequencing instruments, and to assess the physical requirements – such as power consumption, cooling, data transfer, and space constraints – that an optimal computational solution for research and clinical teams would require.”